Sterling Investment Management Inc increased its stake in Johnson & Johnson (JNJ) by 394.06% based on its latest 2018Q3 regulatory filing with the SEC. Sterling Investment Management Inc bought 10,147 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 12,722 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $1.76M, up from 2,575 at the end of the previous reported quarter. Sterling Investment Management Inc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $365.77B market cap company. The stock increased 1.54% or $2.07 during the last trading session, reaching $136.38. About 6.67M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since February 16, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 05/05/2018 – New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid lmprovements in Depressive Symptoms in Patients with Treatment-Resistant Depression; 23/04/2018 – DJ Johnson & Johnson, Inst Holders, 1Q 2018 (JNJ); 17/04/2018 – Johnson & Johnson Raises 2018 View To Sales $81B-$81.8B; 14/03/2018 – CN RAIL INTERIM CEO JJ RUEST SPEAKS AT JP MORGAN CONFERENCE; 25/04/2018 – J&J GETS COURT TO THROW OUT $151 MILLION DEPUY HIP VERDICT; 12/04/2018 – Johnson & Johnson’s Janssen: INVOKANA Showed Significant Renal Protective Benefits in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease; 06/03/2018 – Johnson & Johnson to Participate in Barclays Global Healthcare Conference; 03/05/2018 – J&J Presenting at UBS Conference May 21; 18/04/2018 – Kentucky accuses J&J of contributing to opioid epidemic; 17/04/2018 – Johnson & Johnson Sees About $600M-$800M Annual Pretax Cost Savings by 2022

Walter & Keenan Financial Consulting Company decreased its stake in Jpmorgan Chase & Co (JPM) by 7.26% based on its latest 2018Q3 regulatory filing with the SEC. Walter & Keenan Financial Consulting Company sold 5,000 shares as the company’s stock declined 10.86% with the market. The institutional investor held 63,853 shares of the major banks company at the end of 2018Q3, valued at $8.21 million, down from 68,853 at the end of the previous reported quarter. Walter & Keenan Financial Consulting Company who had been investing in Jpmorgan Chase & Co for a number of months, seems to be less bullish one the $350.95B market cap company. The stock increased 3.06% or $3.13 during the last trading session, reaching $105.55. About 14.72 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has declined 3.12% since February 16, 2018 and is downtrending. It has underperformed by 3.12% the S&P500. Some Historical JPM News: 06/04/2018 – Trade war ‘is the greatest threat to the world economy’, JP Morgan’s Frenkel says; 30/04/2018 – JPMorgan Disciplined Equity Adds Medtronic, Exits Costco; 14/05/2018 – ForeScout Technologies at JPMorgan Conference Tomorrow; 21/05/2018 – Cimarex Presenting at JP Morgan Energy Bus Tour Tomorrow; 24/04/2018 – KONINKLIJKE PHILIPS NV PHG.AS : JP MORGAN RAISES TARGET PRICE TO 36.7 EUROS FROM 35.6 EUROS; 14/05/2018 – Western Digital Presenting at JPMorgan Conference Tomorrow; 09/05/2018 – Tegna Presenting at JPMorgan Conference May 16; 16/05/2018 – Boingo Wireless Presenting at JPMorgan Conference Tomorrow; 24/05/2018 – Correction: Fitch Rates J.P. Morgan Mortgage Trust 2018-2; 05/04/2018 – JPMorgan CEO Sees Long Timeline, Big Goals for Health Venture

Among 34 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 14 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 129 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, February 13 by Keefe Bruyette & Woods. As per Monday, January 18, the company rating was upgraded by Atlantic Securities. Oppenheimer maintained the stock with “Hold” rating in Thursday, July 20 report. RBC Capital Markets maintained it with “Buy” rating and $9500 target in Thursday, June 15 report. BMO Capital Markets maintained the shares of JPM in report on Monday, July 16 with “Market Perform” rating. The rating was maintained by Jefferies on Tuesday, June 6 with “Buy”. The company was downgraded on Tuesday, January 8 by Jefferies. Nomura downgraded the stock to “Neutral” rating in Monday, January 25 report. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Underperform” rating by Portales Partners on Monday, February 22. As per Wednesday, August 23, the company rating was maintained by BMO Capital Markets.

Since October 19, 2018, it had 2 insider purchases, and 5 selling transactions for $4.86 million activity. CROWN JAMES S bought 5,000 shares worth $518,950. On Tuesday, January 29 the insider Friedman Stacey sold $317,310. 1,150 JPMorgan Chase & Co. (NYSE:JPM) shares with value of $125,281 were bought by HOBSON MELLODY L. 13,341 shares were sold by Beer Lori A, worth $1.40M. $1.96 million worth of JPMorgan Chase & Co. (NYSE:JPM) was sold by Scher Peter on Tuesday, January 29. Petno Douglas B also sold $1.22 million worth of JPMorgan Chase & Co. (NYSE:JPM) shares.

Walter & Keenan Financial Consulting Company, which manages about $337.76M and $334.04 million US Long portfolio, upped its stake in Texas Instrs Inc (NASDAQ:TXN) by 5,150 shares to 11,849 shares, valued at $1.27M in 2018Q3, according to the filing.

More notable recent JPMorgan Chase & Co. (NYSE:JPM) news were published by: Seekingalpha.com which released: “JPMorgan – 5.75% Forever – Seeking Alpha” on September 18, 2018, also Fool.com with their article: “Is JPMorgan Chase a Buy? – Motley Fool” published on December 03, 2018, published: “Insider Buys Of The Week: ADM, AT&T, JPMorgan And More – Yahoo Finance” on February 11, 2019. More interesting news about JPMorgan Chase & Co. (NYSE:JPM) were released by: Fool.com and their article: “Better Buy: Bank of America vs. JPMorgan – Motley Fool” published on January 26, 2019 as well as ‘s news article titled: “JPMorgan Expands Bond ETF Lineup – Benzinga” with publication date: January 31, 2019.

Investors sentiment decreased to 0.95 in Q3 2018. Its down 0.04, from 0.99 in 2018Q2. It worsened, as 37 investors sold JPM shares while 755 reduced holdings. 124 funds opened positions while 628 raised stakes. 2.32 billion shares or 1.12% less from 2.34 billion shares in 2018Q2 were reported. Invest House Lc has invested 0.07% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Cove Street Limited Liability holds 0.92% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 77,606 shares. Alpine Woods Cap Invsts Llc invested in 0.73% or 31,310 shares. Colonial Trust Advsr invested in 2.14% or 101,478 shares. Bsw Wealth Ptnrs invested in 0.34% or 7,839 shares. Moreover, Arbor Advisors Limited Liability Corp has 0.08% invested in JPMorgan Chase & Co. (NYSE:JPM). Blume Capital Management Inc accumulated 1.74% or 29,461 shares. Lombard Odier Asset Management (Switzerland) holds 0.17% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 15,518 shares. Woodmont Investment Counsel Ltd Liability Co has 33,511 shares for 1.03% of their portfolio. Cornerstone Advisors Inc accumulated 282,000 shares. The North Carolina-based Willingdon Wealth Mgmt has invested 1.84% in JPMorgan Chase & Co. (NYSE:JPM). Franklin Resource reported 1.33% stake. Utd Advisers Limited Com holds 0.56% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 703,680 shares. Ohio-based Diamond Hill Cap Inc has invested 1.65% in JPMorgan Chase & Co. (NYSE:JPM). Valmark Advisers Inc reported 3,696 shares.

Since August 27, 2018, it had 3 insider buys, and 8 sales for $79.44 million activity. On Friday, November 23 Sneed Michael E sold $4.41 million worth of Johnson & Johnson (NYSE:JNJ) or 30,943 shares. Gorsky Alex sold $38.60 million worth of Johnson & Johnson (NYSE:JNJ) on Friday, November 16. On Monday, December 3 Fasolo Peter sold $24.41 million worth of Johnson & Johnson (NYSE:JNJ) or 166,695 shares. On Wednesday, November 7 the insider Duato Joaquin sold $5.77 million. Another trade for 3,643 shares valued at $536,638 was sold by Kapusta Ronald A. Another trade for 748 shares valued at $100,050 was bought by MULCAHY ANNE M.

Investors sentiment increased to 1.05 in Q3 2018. Its up 0.08, from 0.97 in 2018Q2. It improved, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Cibc Asset Mngmt Inc accumulated 272,082 shares. Benedict Finance Advisors Inc has invested 3.31% in Johnson & Johnson (NYSE:JNJ). Eagle Asset Mngmt Inc stated it has 826,573 shares. Atria Ltd Limited Liability Company accumulated 57,920 shares. Selway Asset Mngmt invested in 1.31% or 15,780 shares. Wellington Shields & Llc owns 14,266 shares or 1.07% of their US portfolio. 12.46M were accumulated by Deutsche Bancorporation Ag. Vanguard Grp Inc invested in 1.15% or 213.43 million shares. Cohen & Steers has 184,026 shares. Profund Advisors has 138,075 shares for 0.72% of their portfolio. Swift Run Cap Mngmt Limited Liability invested 0.24% in Johnson & Johnson (NYSE:JNJ). Employees Retirement Association Of Colorado invested in 1.50 million shares. Moreover, Baldwin Inv Management Limited Liability Com has 0.51% invested in Johnson & Johnson (NYSE:JNJ). Lowe Brockenbrough Communications has 107,142 shares for 2.07% of their portfolio. Covington Investment has 1.31% invested in Johnson & Johnson (NYSE:JNJ).